We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
StemCells Regains Compliance for Continued NASDAQ Global Market Listing
News

StemCells Regains Compliance for Continued NASDAQ Global Market Listing

StemCells Regains Compliance for Continued NASDAQ Global Market Listing
News

StemCells Regains Compliance for Continued NASDAQ Global Market Listing

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "StemCells Regains Compliance for Continued NASDAQ Global Market Listing"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

StemCells, Inc., has announced that it has received notification from The NASDAQ Stock Market that the Company has regained compliance with the minimum bid price requirement.

In order to continue listing on the NASDAQ Global Market, the NASDAQ Listing Rules require the Company’s stock to evidence a closing of bid price of $1.00 per share or more for ten consecutive days.

On July 20, 2011, the closing bid price of the Company’s common stock was $3.75 per share, the tenth consecutive day the bid price closed above $1.00 per share.

Advertisement